Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Environmental
- Health and Safety
- Water and Wastewater
- Food and Beverage
- Energy
- Oil, Gas & Refineries
- Agriculture
- Air and Climate
- Manufacturing, Other
- Mining
- Aerospace & Air Transport
- Logistics
- Pulp & Paper
- Waste and Recycling
- Soil and Groundwater
- Government
- Publishing / Media / Marketing
Oncology Suppliers Serving Nepal
334 companies found
based inSan Diego, CALIFORNIA (USA)
Cortechs.ai is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, better lives. The company develops and markets breakthrough ...
OnQ Neuro is FDA-cleared post-processing software used by radiologists, oncologists, and other clinicians to assist with the analysis and quantification of MR images of brain ...
based inLaval, QUEBEC (CANADA)
Maranda Lauzon is a family owned and operated business, specializing in the distribution of products and services in the medical imaging industry for more than 35 years. Throughout the years, we have built a solid reputation for the diversity of our ...
based inElma, NEW YORK (USA)
Quickset Defense Technologies, LLC, aka Quickset formerly known as Moog Sensor and Surveillance Systems, designs and produces high-quality positioners and scalable physical security and process monitoring solutions for extreme environments. Our ...
based inManchester, UNITED KINGDOM
Yourgene Health is a leading international molecular diagnostics group with an integrated portfolio of technologies and services to enable genomic medicine. Our mission to enable scientific advances to positively impact human health remains at the ...
At Yourgene Genomic Services we believe every patient can benefit from understanding their unique genomic ...
based inFlorence, ITALY
The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, ...
MEN1309 is an antibody-drug conjugate (ADC) constituted by a fully human IgG1 antibody conjugated through a cleavable linker to a cytotoxic agent (a maytansin derivative, DM4), responsible for its antitumor activity. The target antigen, CD205, is ...
based inChicago, ILLINOIS (USA)
GE HealthCare operates as a leader in precision care, integrating advanced technologies with patient-focused solutions to enhance healthcare delivery. The company invests approximately $1 billion annually in research and development, focusing on ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inHod Hasharon, ISRAEL
Virtual Ports designs and manufactures the only specialized retraction devices capable of using 5mm existing ports to retract organs entirely from within the body cavity to help surgeons overcome this challenge and to achieve a higher level of ...
The EndoLift™ port-free retractor is specifically designed for retraction of larger soft-tissue structures such as the liver and uterus from within the body cavity through an existing port. Virtual Ports proprietary MicroAnchoring™ ...
based inDowners Grove, ILLINOIS (USA)
Shared Imaging provides top-tier diagnostic imaging systems and services, optimizing MRI, PET/CT, CT, and Women's Health systems acquisition through innovative, cost-effective methods. Leveraging extensive expertise as owners, operators, and service ...
The decay of these tracers is detected by the PET scanner, which creates physiologic maps of relevant functions or processes. Clinically, FDG, a glucose analog, is commonly used to image glucose metabolic rates in oncologic studies, ...
based inWaltham, MASSACHUSETTS (USA)
Evident, we’re building on this legacy with a continued commitment to pushing the limits of discovery. Today, as Evident, we’re building on a century of optical superiority to create next-generation micro-imaging solutions—combining renowned optics ...
based inSeoul, SOUTH KOREA
NGS industries are rapidly evolving and our customers are in greater need of technical support in various research fields and markets. Just like a chameleon utilizing its colored pigments and crystals to adapt to its surroundings, we proactively ...
Celemics’ BRCA 1,2 Target Enrichment Panel is designed to enrich whole coding sequences (CDS) of the BRCA1 and BRCA2 genes including UTR, promoter, and +/- 40 bases of CDS to detect the variants in the splicing ...
based inMarseille Cedex 9, FRANCE
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...
The most popular Nanostring service we offer is the nCounter® PanCancer IO 360™ Panel. This panel is designed to deliver immuno-oncology insights for translational research and assesses the expression of 770 genes involved ...
based inParsippany, NEW JERSEY (USA)
Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. Since our ...
based inGosselies, BELGIUM
We are a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. OncoDNA is a company specializing in precision for the treatment of cancer and other genetic diseases. We are ...
based inOrvault, FRANCE
ATA was born in 1987 in Nantes, in France, and quickly became an expert in air handling units for various sectors: data centers, telecommunications, food industry, pharmaceuticals, etc. Few years later, ATA started to provide air treatment solutions ...
based inFramingham, MASSACHUSETTS (USA)
At Definitive Healthcare, our passion is to transform data, analytics and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities and people, so they can shape tomorrow’s healthcare industry. Our ...
Developing new products means matching customers’ needs with accurate market sizes. Once you understand the market opportunity, you can focus on what’s most important. With Definitive Healthcare Solutions for Product Development, you ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Tarlatamab has the KDs of 14.9 nM and 12 nM for human and NHP CD3, respectively. Tarlatamab is a first-in-class HLE BiTE immuno-oncology therapy targeting DLL3 and has the potential for SCLC ...
based inMalvern, PENNSYLVANIA (USA)
A proven pioneer and partner to the diagnostics industry. Fujirebio is an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby ...
based inTampa, FLORIDA (USA)
Concept Medical is driving innovation in medical devices, with a focus on developing technologies for drug delivery with a strong emphasis on intellectual property. Based in Tampa, Florida; Concept Medical has always striven to find solutions to ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
DSP-0390 is an emopamil-binding protein (EBP) inhibitor. EBP is an endoplasmic reticulum membrane protein involved in cholesterol biosynthesis.47 When functional, EBP mediates de novo cholesterol synthesis for cell membrane structure and signaling, ...
